| Financial Year |
March 31 2023 |
| Monetary Funds |
125,024,609.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,879,972.01 |
| Accounts Receivable |
598,486,973.81 |
| Advances to Suppliers |
71,983,202.91 |
| Other Receivables |
14,552,963.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
111,037,865.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,475,556.26 |
| Total Current Assets |
992,078,163.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
228,450,069.82 |
| Under-construction Projects |
20,507,795.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,285,841.46 |
| R&D expenses |
-- |
| Goodwill |
173,212,299.50 |
| Long-Term Deferred and Prepaid Expenses |
15,937,337.55 |
| Deferred Income Tax Assets |
28,334,497.71 |
| Other Non-Current Assets |
963,034.51 |
| Sub-Total of Non-Current Assets |
495,342,307.20 |
| Total Assets |
1,487,420,470.41 |
| Short-Term Loans |
158,154,281.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
248,904,388.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,093,283.51 |
| Taxes Payable |
9,993,947.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,130,876.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
149,985,138.51 |
| Other Current Liabilities |
5,270,675.00 |
| Sub-Total of Current Liabilities |
629,826,504.09 |
| Long-term Loans |
155,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
26,370,793.69 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
183,689,157.47 |
| Total Liabilities |
813,515,661.56 |
| Paid-In Capital(Or Share Stock) |
124,753,300.00 |
| Capital Surplus |
66,527,210.47 |
| Surplus Reserve |
55,059,011.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
332,962,320.47 |
| Minority Stockholder's Interest |
94,602,966.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
579,301,842.58 |
| Owner's Equity（Stockholder's Equity） |
673,904,808.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,487,420,470.41 |
